Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
31540 | 121 | 25.5 | 46% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2664 | 2947 | METHYLSULFONYLMETHANE//LEUKEMIA CELL DIFFERENTIATION//N ACETYL S N METHYLCARBAMOYLCYSTEINE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | IMMUNOCYTOFLUOROMETRY | Author keyword | 1 | 33% | 2% | 2 |
2 | CLASS II DR | Author keyword | 1 | 50% | 1% | 1 |
3 | CLIN STOMATOL 1 | Address | 1 | 50% | 1% | 1 |
4 | DOUBLE FLUORESCENT LABELING | Author keyword | 1 | 50% | 1% | 1 |
5 | ENDOCYTOTIC VACUOLES | Author keyword | 1 | 50% | 1% | 1 |
6 | FLOW IMMUNOCYTOMETRY | Author keyword | 1 | 50% | 1% | 1 |
7 | HEMATOPOIETIC CELL SUBPOPULATIONS | Author keyword | 1 | 50% | 1% | 1 |
8 | HYPOGRANULAR | Author keyword | 1 | 50% | 1% | 1 |
9 | LYMPHOBLASTIC CELL LINE | Author keyword | 1 | 50% | 1% | 1 |
10 | MALIGNANT GLIOMA CELL LINES | Author keyword | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CD4 MODULATION | 1 | 50% | 1% | 1 |
2 | HUMAN NON T | 1 | 50% | 1% | 1 |
3 | SYNERGISTICALLY INDUCE DIFFERENTIATION | 0 | 33% | 1% | 1 |
4 | TWO DIMENSIONAL ANALYSIS | 0 | 20% | 1% | 1 |
5 | DP ANTIGENS | 0 | 13% | 1% | 1 |
6 | 13 15 TRISOMY SYNDROME | 0 | 100% | 1% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Nuclear envelope-limited chromatin sheets (ELCS) and heterochromatin higher order structure | 2009 | 3 | 61 | 15% |
Protein kinase inhibitors: Induction of apoptosis and drug-resistance modulation in neoplastic cell lines | 1996 | 5 | 59 | 7% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CLIN STOMATOL 1 | 1 | 50% | 0.8% | 1 |
2 | STN 6500 | 0 | 33% | 0.8% | 1 |
3 | SURG 4 TRANSPLANTAT | 0 | 20% | 0.8% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000115421 | T CELL ASSOCIATED ANTIGENS//CD8 ANTIGEN//B CELL NON HODGKIN LYMPHOMA B NHL |
2 | 0.0000096470 | T LYMPHOCYTE IMMUNOLOGY//CLIN HOSP O NOVOSEL MED MED//MITOGEN INDUCED CELLULAR CYTOTOXICITY |
3 | 0.0000080557 | POLYVALENT ANTIGEN//AUTOLOGOUS ANTIBODY//B700 |
4 | 0.0000079395 | UCN 01//7 HYDROXYSTAUROSPORINE//7 HYDROXYSTAUROSPORINE UCN 01 |
5 | 0.0000073453 | INVASION & METASTASIS//CLINICAL & EXPERIMENTAL METASTASIS//ND2001 |
6 | 0.0000064384 | LEUKEMIA CELL DIFFERENTIATION//DUNN OSTEOSARCOMA CELLS//LOW DOSE CYTOSINE ARABINOSIDE |
7 | 0.0000062506 | MUCOPOLYSACCHARIDE POLYSULFATE//CAS 530 78 9//PERFUSED PIG EAR |
8 | 0.0000062281 | LARGE CHANNEL ENDOCYTOSIS//NEUROSCI CYTOL//THIAZINE DYE |
9 | 0.0000060593 | SMALL CELL LUNG CANCER CELL LINE//SMALL CELL LUNG CANCER CELL LINES//DRUG SCREENING ASSAY |
10 | 0.0000058693 | SKIN ISCHEMIA//SO BUR//KRASNODAR BRANCH |